A retrospective review was conducted at a tertiary center between 2019 and 2022. Patients with reported latex allergies who underwent linear EUS were included. Baseline demographics, EUS characteristics, and adverse events were collected. The primary outcome was the rate of adverse events.
Eighty-seven procedures were performed on 57 unique patients (mean age, 65.3 ± 14.5 years). Latex balloons were used in 59 procedures (67.8%), with only 8 procedures (13.6%) using prophylactic medications. No adverse events occurred during or after procedures, regardless of medication use or history of anaphylaxis.
The use of EUS latex balloons in patients with a latex allergy was associated with no adverse events.
方法:在2019年至2022年之间在三级中心进行了回顾性审查。包括报告有乳胶过敏并接受线性EUS的患者。基线人口统计,EUS特性,并收集不良事件。主要结果是不良事件的发生率。
结果:对57名独特患者进行了87次手术(平均年龄,65.3±14.5年)。在59个手术中使用了乳胶气球(67.8%),只有8个程序(13.6%)使用预防性药物。术中或术后无不良事件发生,无论药物使用或过敏反应史。
结论:乳胶过敏患者使用EUS乳胶球与无不良事件相关。